NUBEQA 300 mg, Filmtabletten

7680675210015 CH-67521 Filmtabletten

Associated product:

NUBEQA cpr pell 300 mg 112 pce
NUBEQA 300 mg, Filmtabletten
NUBEQA 300 mg, Filmtabletten
NUBEQA 300 mg, Filmtabletten
1 / 3
google

Article details

Package size
112
Selling units
112
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
31/07/2025
Patient information leaflet
Français
31/07/2025
Patient information leaflet
Italien
31/07/2025
Summary of Product Characteristics
Allemand
31/07/2025
Summary of Product Characteristics
Français
31/07/2025
Summary of Product Characteristics
Italien
31/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.7 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
186.0 MG Substance HBESI

Reimbursement information

Public price
CHF 3203.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2023

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
67521
Drug name
NUBEQA, Filmtabletten
Galenic form
FILM
ATC Code
L02BB06
Authorization status
Z
Dispensing category
B
First authorization
19/06/2020
Authorization expiration date
31/12/9999
IT Number
07.16.2.
Domain
Human medicine
Field of application
nicht-metastasiertes, kastrationsresistentes Prostatakarzinom (nmCRPC); metastasiertes, hormon-sensitives Prostatakarzinom (mHSPC)

Package details

Description (FR)
NUBEQA cpr pell 300 mg 112 pce
Description (DE)
NUBEQA Filmtabl 300 mg 112 Stk
Market launch
19/06/2020
Narcotic (BTM)
No